'Triple negative' breast cancer: a new area for phase III breast cancer clinical trials

Clin Oncol (R Coll Radiol). 2008 Feb;20(1):35-9. doi: 10.1016/j.clon.2007.09.010. Epub 2007 Oct 31.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / chemistry*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Clinical Trials, Phase III as Topic
  • Female
  • Humans
  • Prognosis
  • Receptor, ErbB-2 / analysis
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Survival Rate

Substances

  • Receptors, Estrogen
  • Receptors, Progesterone
  • Receptor, ErbB-2